Because of the lack of de novo purine biosynthesis, hypoxanthine-guanine phosphoribosyltransferase (HGPRTase) is a critical enzyme in the purine metabolic pathway of the human parasite, Schistosoma mansoni. Using a cDNA clone encoding mouse HGPRTase and subsequently a synthetic oligonucleotide derived from sequencing a clone of genomic DNA, two clones were isolated from an adult schistosome cDNA library. One clone is 1.374 Kilobases (Kb) long and has an open reading frame of 693 bases. The deduced 231 amino acid sequence has 47.9% identity in a 217 amino acid overlap with human HGPRTase. Northern blot analysis indicates that the full length of mRNA for the S. mansoni HGPRTase is 1.45-1.6 Kb. Analysis of the primary structures of the putative active site for human and parasite enzymes reveal specific differences which may eventually be exploitable in the design of drugs for the treatment of schistosomiasis.
INTRODUCTION
Many parasites are known to lack enzymes for de novo biosynthesis of purines (1) (2) (3) (4) (5) (6) (7) (8) . For this reason, enzymes involved in the salvage of purine bases and nucleosides have been proposed to be potential targets for antiparasitic chemotherapy (9) (10) (11) (12) (13) (14) (15) (16) . HGPRTase is of particular interest because it plays a major role in replenishing purine nucleotides for a number of parasites (6) (7) (8) 17) . Furthermore, the mammalian HGPRTase has been extensively studied because of its implication in gout (18) , Lesch-Nyhan syndrome (19) and to its usefulness in the selection of human-mouse cell hybridomas (20) . The primary structure for the HGPRTase of humans (21, 22) as well as the deduced amino acid sequence (from cDNA sequence analysis) of the HGPRTase of mice and hamsters (23) have been reported. Hershey and Taylor (24) have aligned the deduced amino acid sequences of the mammalian HGPRTases with those deduced for the adenine phosphoribosyltransferase (APRTase) of E. coli, the APRTase of mice (25) , and with bacterial glutamine phosphoribosyltransferase (26) , xanthine-guanine phosphoribosyltransferase (27, 28) , and orotate phosphoribosyltransferase (29) . These alignments plus the results of genetic studies (30, 31) permitted Hershey and Taylor to postulate specific sequences as the likely phosphoribosylpyrophosphate (PRPP) and purine binding sites of HGPRTase.
Schistosoma mansoni is one of the three major species of trematode parasites that cause schistosomiasis (Bilharzia). This disease is endemic throughout most of the tropical world and affects over 200 million people, making it one of the world's greatest health problems (32) . S. mansoni has long been known to lack the capability of de novo purine synthesis (2) . Our recent studies on the schistosomula of S. mansoni indicate that the organisms depend primarily on salvaging purine bases to fulfill their requirement for purine nucleotides (8, 15) . Due to the limited interconversion between adenine and guanine nucleotides, the HGPRTase of S. mansoni provides the major source of guanine nucleotides for the parasite. An effective inhibition of this enzyme is anticipated to have a lethal effect on the parasite. This enzyme has been purified to homogeneity from adult worms of S. mansoni and demonstrates several properties which distinguish it from the enzymes of mammals (15) . These observations and the availability of structural information from mouse and human clones encouraged us to attempt to clone and sequence the cDNA's encoding parasite HGPRTases with the aim of comparing the putative PRPP and purine binding sites of the host and parasite enzymes. A significant difference in the primary structures of these binding sites would justify further characterizations of the parasite enzyme for specific inhibitor design.
MATERIALS AND METHODS

Screening of S. mansoni cDNA libraries
Lambda gt11 S. mansoni cDNA libraries, prepared from adult worm poly (A) mRNA were prepared as previously described (33) the only modification being that after digestion with Eco R1, fragments larger than 1.5 Kb were enriched for by agarose gel electrophoresis. For screening, phage were plated at a density of 5-10 X 10 5 plaque forming units (pfu) per 150 mm plate on a lawn of Escherichia coli, strain Y-1090. Double nitrocellulose lifts were prepared according to standard methods (34, 35) . The filters were probed with a 691 base pair (bp) Ddel restriction fragment of the pHPT5 plasmid (23; kindly provided by Dr. Tom Caskey of Baylor College of Medicine in Houston, TX). This fragment contains the entire coding sequence for mouse HGPRTase plus 37 bp upstream of the start codon. The probe was radiolabeled using a nick translation kit from Bethesda Research Laboratories (BRL) and a-32p-<jCTP from Amersham. Specific radioactivity of the probe usually exceeded 10 7 cpm/uxj DNA. Prehybridization and hybridization solutions contained 30%
formamide (deionized), 5 X standard sodium citrate (SSC, 0.15 M NaCI, 0.015 M Nacitrate, pH 7.0), 0.1% sodium dodecyl sulfate (SDS), 1 mM EDTA, 10 mM Tris, pH 7.5, 1 X Denhardts' and 100 u.g/ml heparin. Filters were prehybridized at least 1 hr before adding the freshly denatured nick translated probe to a concentration of more than 10 washed with 5 X SSC and 0.2% SDS at 42°, blotted dry and autoradiographed with an intensifying screen at -70°. Positive plaques were isolated and the phage were repeatedly plated and screened until 100% of the plaques on a plate hybridized with the probe.
Additional cDNA clones were isolated by using 20 base long oligonucleotides synthesized by the Biomolecular Resource Center at UCSF (see Fig. 1 ). These oligonucleotides were based on sequences identified during partial sequencing of a genomic clone (36) . One hundred nanograms of the synthetic oligonucleotide was radiolabelled using 2 units of T4 polynucleotide kinase from BRL with ^3 2 P -A T P (3,000 Ci/mmole) from Amersham. Oligonucleotides thus labeled were separated from y-32p./vTP by centrifugation at 2,000 x g for 4 min at 4° through a G-25 Sephadex spin column from Boehringer/Mannheim. Hybridization with the labeled oligonucleotide was for 18 hours at 47° at a concentration of 10 6 -10 7 cpm/ml in 6 X SSC, 10 X Denhardt's, 0.1% SDS, 0.1 mg/ml heparin, and 1 mM EDTA. The filters were washed with 5 changes of 6 X SSC, 0.1% SDS at 47° and autoradiographed. Purification of lambda phage DNA Lambda phage DNA was prepared by plating the phage at 10 5 pfu per plate on two 150 mm plates. Confluent lysis was achieved at 42° after approximately 12 hours. The phage were recovered by rotating the plates at 4° after the addition of 8-10 ml of SM buffer (35; 0.1 M NaCI, 8 mM MgSO4, 0.2% gelatin, 50 mM Tris, pH 7.5). The buffer was collected after 12-16 hours and centrifuged at 2,000 x g for 5 minutes at 4°. The pellets were discarded and DNase I (Sigma) and T1 RNase (Boehringer/ Mannheim) were added to final concentrations of 0.3 ng/ml and 33 units/ml, respectively. After incubation at room temperature for 15 min, the sample was recentrifuged at 2,000 x g for 10 min at 4°, and the supernatant was extracted with an equal volume of chloroform and recentrifuged at 2,000 x g for 15 min at 4°. The supernatant was distributed equally among three SW 41 tubes (from Beckman), each containing 3.3 ml of 10% glycerol in TM buffer (35; 10 mM MgS04, 50 mM Tris, pH 7.8) overlaying a 3 ml cushion of 40% glycerol in TM buffer. After centrifugation for 1 hr at 35,000 rpm at 4° in a SW 41 rotor, the supernatants were removed and the pellets resuspended in a total volume of 300 ^\ of TM. DNase I and T1 RNase were added to final concentrations of 5 ng/ml and 330 units/ml, respectively, and incubated at 37° for 30 min. EDTA (20 mM, pH 8), proteinase K (100 ug/ml), and SDS (0.5%) were added and followed by incubation at 65° for another hr. The sample was extracted successively with equal volumes of phenol, phenol/chloroform (1:1) and chloroform with 1 min microcentrifugations between extractions to separate phases. The DNA was precipitated from the aqueous phase by the addition of 0.5 volume of 7.5 M NH4-acetate followed by an equal volume of isopropanol. The pellet was collected after 10 min at -20° by micro-centrifugation and washed with 95% ethanol. Yields of phage DNA usually ranged from 20 to 200 ng. Subcloning and sequencing cDNA inserts The cDNA inserts were removed from the purified, cloned phage DNA by digestion with EcoR1 and were ligated into the dephosphorylated EcoR1 site of "Bluescript" from Stratagene. The plasmid DNA was used to transform Escherichia coli, strain dg98, and was purified from 500 ml liquid cultures of the transformed bacteria. The bacteria were harvested (2,000 x g for 10 min at 4°) and resuspended in 20 ml of the STET buffer (35; 0.1 M NaCI, 0.1 mM EDTA, 0.5% Triton X-100, and 10 mM Tris, pH 8.0) containing lysozyme at 0.5 mg/ml. The sample was rapidly brought to boiling over a Bunsen burner and maintained at 100° with gentle mixing for 2 additional min prior to cooling and centrifuging at approximately 30,000 x g for 30 min at 4°. Subsequent treatments with proteinase K, extraction with phenol, phenol/chloroform and chloroform, and banding in CsCI after intercalation with ethidium bromide were done according to standard methods (35) . Yields of the plasmid DNA were usually about 1 jig/ml of the original bacterial culture. For sequencing the cDNA insert, the purified plasmid was annealed with SK and KS oligonucleotide primers (from Stratagene), and sequenced by the dideoxy chain termination method (37) using a "Sequenase" kit and protocols from United States Biochemicals. For these reactions, a-35 S-dATP (Amersham) was used for isotopic labeling and inosine triphosphate was substituted forGTP in the elongation reaction in order to reduce the effects of secondary structure on electrophoretic mobility (38) (39) (40) . Complete sequencing of both strands of cDNA inserts was facilitated by the use of ten different 20 base long oligonucleotides prepared by the Biomolecular Resource Center at UCSF (see Fig. 1 ).
Probing of Northern blots
Total RNA was extracted from the hepatopancreas of S. mansoni infected Biomphalaria glabrata snails (the intermediate host for schistosomes) as previously described (41) . RNA from uninfected snails was included as a control. The RNAs were resolved in MOPS-formaldehyde-agarose gels and transferred to nitrocellulose filters according to standard procedures (35) . The blots were probed with the nick translated cDNA insert which had a specific radioactivity exceeding 10 7 cpm/uxj DNA.
Hybridizations were performed as described above except that the hybridization temperature was 55° and the filters were washed with 1 X SSC, 0.2% SDS at 65°. Computer analysis of deduced protein structure
Predictions for the secondary structure of protein were performed according to Chou and Fassman (42, 43) while hydrophobicity plots were generated using parameters established by Kyle and Doolittle (44) .
RESULTS
The cDNA encoding S. mansoni HGPRTase The use of a 691 bp cDNA fragment from pHPT5, encoding mouse HGPRTase, to probe for complementary sequences within a lambda gt11 S. mansoni cDNA library resulted in the identification of a single clone, designated Smc1, among approximately 200,000 phage plaques. The clone was purified to homogeneity, and the cDNA insert subcloned and sequenced (Fig. 1) . Smc1 was then used to reprobe the same cDNA library under more stringent hybridization conditions (at 55°), yielding several homologous clones with partial cDNA inserts at a frequency of 1/50,000 phage plaques. Eventually, a 1374 bp cDNA clone, Smc2, was identified by screening the cDNA library with a 20 base synthetic oligonucleotide that is homologous to an upstream coding sequence (P in Fig. 1 length, were sequenced and the results are presented in Figs. 1 and 2 . Since the entire sequence of S m d is duplicated within Smc2 (Fig. 1) , much of the following data refers only to clone Smc2. Smc2 has a long open reading frame (ORF-1) starting with the 5'end, coding for a protein with 231 amino acid residues adding up to a molecular weight of 26,000 daltons ( Fig. 2) and which possesses 47.9% identity in a 217 amino acid overlap with human HGPRTase and 36.9% identity in a 222 amino acid overlap with Plasmodium falciparum HGPRTase (see Fig. 4 ). When chemically similar amino acid substitutions are counted as no substitution, the amino acid sequence for the schistosomal HGPRTase has 67.3% and 59.4% agreement with the sequences for human and malarial HGPRTase, respectively. Codon usage appears to be nonrandom for some of the amino acids such as leucine, valine, proline, threonine, asparagine, arginine, and glycine. With the exception of valine, most of the codons seem to prefer the usage of A and T which is reflected in an AT content of 60.8% in the ORF-1 of Smc2 (Fig. 2 ).
Within the 3" tail of Smc2 there is a second open reading frame (ORF-2) beginning with a methionine and running for 51 amino acids (Fig. 1) . The start codon for this open reading frame is in a favorable environment for initiation of translation as there is an A in the -3 and a C in the +4 position relative to the AUG codon (see 45, 46) . Thus, this open reading frame could theoretically be translated. However, the predicted amino acid sequence does not align significantly with any other proteins in the Dayhoff database using the Lipman & Pearson "dfastp" program (47) . Also within the 3' tail, there are three AATAAA poly (A) addition signals (Fig. 2) , two 13 base sequences, TATCCTATCTATA, and two 8 base sequences, TATACTAT and TCTATACT appearing 4 times each in a region 140-240 bases downstream from the stop codon. The significance of these repeated sequences is not known.
Hybridization of nick translated S m d with the Northern blots indicated that there may be a single species of mRNA encoding S. mansoni HGPRTase (Fig. 3) . The size of the mRNA is estimated to be 1.45 to 1.60 Kb. Conservatively assuming that the mRNA may have a poly (A) tail of about 100 bases (16) , whereas Smc2 has a size of 1374 bases and a poly (A) 3'-end of 15 bases, Smc2 may miss about 100 bases representing the 5'-end of the mRNA. Analysis of the protein structure deduced from the cDNA Alignments of predicted amino acid sequence (Fig. 4) for the coding region of Smc2 with sequences for the HGPRTases of humans (22) and the malarial parasite, P. falciparum (16) , allow identification of putative purine and phosphoribosylpyrophosphate binding sites in the parasite enzyme (24) . Between amino acid positions 40 and 78, there is a predicted p-a-p" structure in all three enzymes (Fig. 4) . Many nucleotide binding proteins are known to possess this structure, which is characterized as a mononucleotide fold presumably involved in binding to PRPP among the phosphoribosyltransferases (48) . Interestingly, the position and length of the predicted P-a-p structures is nearly identical for the human and schistosomal enzymes, even though primary structure has diverged extensively, with less than 1 1 % identity within the amino acid sequences from position 54 to 76. Two amino acids from the end of the second p structure (at aa # 77) begins a 13 amino acid long sequence proposed to be a part of the purine binding site of mammalian enzymes (24) . Within this region the schistosomal sequence differs from that of the human by only one nonconservative and one conservative substitution. On the other hand, the enzyme from Plasmodium differs substantially, particularly with the presence of the serine-arginine-glycine residues (position 82-84). A serine-arginine-glycine sequence also appears in the putative purine binding site of bacterial XGPRTase and murine APRTase (Fig. 5) . All three HGPRTases appear to have a p turn at position 79 and the second half of the putative purine binding site is predicted to possess at least some a helical structure. The tyrosine and serine residues, also apparently important for purine binding (24, 31) are found in all of the purine phosphoribosyl transferases at position 118-119 (Fig. 5 ) and are located just to the carboxyl side of a predicted p turn in the human, schistosomal, and malarial enzymes (Fig. 4) . Although the serine residue at position NDQSTGDIKVIGGDDLSTLTGKNVLIVEDIIDTGKTMQTLLSLVRQYNPKMVKVASLLVKRT Regions with the symbol p represent areas of predicted beta secondary structure; those with a are predicted to be alpha helical; and + symbols show where there is a strong prediction for a beta turn (42, 43) .
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124 of the HGPRTases is not found in other purine PRTases (after 24), it is probably involved with a p turn that can affect affinity for purine substrates (30; see Discussion). A 15 amino acid segment at position 142-156 of the schistosomal enzyme aligns well with part of the putative phosphoribosylpyrophosphate binding site (24) , and differs from the sequence in the human enzyme by only a single neutral amino acid substitution of valine for isoleucine (Fig. 4 & 5) . In this same region the schistosomal enzyme differs from that of Plasmodium by the same neutral substitution plus a substitution of asparagine for histidine at position 143. Chou and Fasman analysis (42, 43) predicts that the human, schistosomal and malarial enzymes would be in p conformation in this region with p turns just upstream at position 139, and with a p turn at position 152. There is an additional, well conserved region in the human, schistosomal and malarial enzymes riear the carboxyl end (position 190-216). Within this region there is 81% identity in amino acid sequence for the human and schistosomal proteins and 70% identity for those of schistosomes and Plasmodium. Also, within this region there is only one nonconservative substitution between the sequence for the human and schistosomal enzymes while there are 4 between the sequence for schistosomes and Plasmodium. These areas have not formerly been identified as evolutionarily conserved. However, substitutions of neutral amino acids for the aspartates at positions 208 and 215 have been shown to alter the affinity of HGPRTase for both PRPP and purines (50,51).
Hydrophobicity analysis of the amino acid sequences for the enzymes of humans, schistosomes, and malaria indicate striking similarities with minor differences (Fig. 6) 
DISCUSSION
We have isolated and sequenced cDNA clones coding for the schistosomal HGPRTase. This allows predictions of the amino acid sequence for this pivotal enzyme in schistosome purine metabolism. One issue regarding the sequence is which one of the melhionines at positions 6, 10 or any other upstream or downstream positions of Figure 4 is the actual amino terminus of the enzyme. Using DNA from a genomic clone of schistosomal HGPRTase (36), we have sequenced more than 450 bases upstream from where Smc2 ends. Assuming that this sequence does not contain any introns and will be found in the 5' end of a full length mRNA for HGPRTase, we have focused on the 160 bases immediately upstream from the putative start codon for the schistosomal HGPRTase identified in Fig. 3 . Within this sequence there are two more AUG codons, both in the same reading frame with the sequence reported here for the HGPRTase. The first is 54 and the second 18 amino acids upstream from the methionine at position 6. However, since the first AUG codon has a T in the +4 position and both of these codons have T s in the -3 position, they are considered to be in unfavorable environments to function as start codons, (45, 46) . Actually, the T in the +4 position relative to the methionine at position 6 is not considered to provide the most favorable possible environment for the initiation of translation. However, the methionine at position 10 is in a more favorable environment with A in both the -3 and +4 positions. Furthermore, sequences found within 50 bases of the start codon at position 6 (TCCT, TCCTT, and TCCGC) are complementary to sequences found at the 3' end of the 18s rRNA of a number of eucaryotes (52) . That such sequences could play a role in the initiation of translation has formerly been proposed (52) . Thus, although there remains the possibility that ribosomes would occasionally initiate translation at the two upstream methionines as well as the methionine at positions 6, methionine number 10 is more likely to be found at the amino terminus of the enzyme. The next methionine residue downstream is at position 49. We consider it unlikely to be the N-terminus because it is in the middle of a peptide sequence common to human, malarial and schistosomal HGPRTases.
Northern blot analysis indicates that the mRNA for S. mansoni HGPRTase is 1.45-1.6 Kb. Since Smc2 is 1,374 bp long with a poly (A) tail of only 15 bases, there could be about 100 bases of the mRNA sequence missing from the 5'-end of Smc2 assuming a poly (A) tail of about 100 bases in the mRNA. This evidence suggests that the methionine which appears in genomic sequence 54 amino acids upstream from the methionine at position 6, may be too far upstream to be found in the mRNA. However, the only way to determine with certainty the amino terminus for the schistosomal HGPRTase is to purify enough enzyme to permit sequencing of the amino teminus. This effort is currently underway in our laboratory. Dovey etal. (15) reported that the subunit molecular weight for the HGPRTase of S. mansoni was 64,000 daltons by SDS-PAGE. The molecular weight deduced from cDNA sequencing is slightly over 26,000 daltons. Clearly the length for the mRNA as determined in Northern blots, which agrees well with the size for the mRNAs of mammals (23) and P. faldparum (16), does not allow for an enzyme subunit that could be much over 30,000 daltons. There are two possible explanations for this discrepancy; (1) that S. mansoni HGPRTase was present as a dimer form in SDS-PAGE; or (2) that the enzyme subunit was bound to another protein during SDS-PAGE. Multimerization of HGPRTase was in fact seen by activity staining of a native gradient gel. The native parasite enzyme had a molecular weight of 105,000 daltons (15), consistent with a tetramer of 26,000 dalton subunits. Multimerization also occurs with the native human HGPRTase (53, 54) .
Direct comparison of amino acid sequences for the HGPRTases of Plasmodium and humans yields 48% amino acid identity overall (16) . Although this level of homology is identical to that for the schistosomal and human enzymes, divergence within specific regions of the sequences are dissimilar for Plasmodium and Schistosoma. The most intriguing area of dissimilarity is within the putative purine binding site (at amino acid positions 77-89 of Fig. 4) . Within this region, the malarial enzyme differs significantly with the enzymes of both schistosomes and humans. In particular, the insertion of polar and charged serine and arginine residues at positions 82 and 83 constitute a major alteration in the environment. The significance of this dissimilarity may reside with the recent discovery that the malarial enzyme differs from the human and schistosomal HGPRTases by also recognizing xanthine as substrate, indicating that this enzyme is in fact an HXGPRTase (49) .
Current efforts are focused on purifying more HGPRTase from adult worms in an effort to determine its amino terminal sequence, and to identify and clone the fulllength cDNA for expression within bacteria or yeast. The enzyme thus generated will facilitate purification of the HGPRTase in large quantities and tests of drug sensitivity. Expression will also allow us to plan site directed mutagenesis for the purpose of studying substrate specificity of the enzyme. Also, we hope to crystallize the enzyme for X-ray analysis. These efforts should lead to a clearer picture of the tertiary structure of the active sites of parasite and human HGPRTases, thereby permitting the rational design of drugs to specifically inhibit them.
